Evidence map›Paper›PMID 35411105›Full record

ArticleBone marrow transplantation2022

Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant.

Michael J Shipton, Paul M Kinsella, Thomas Davis, Francesca Azzato, George Taiaroa, Jeff Szer, David Routledge, Olivia Smibert

Abstract readLetter
In one paragraph

Article in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael J ShiptonDepartment of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-3031-5447
Paul M KinsellaDepartment of Microbiology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Thomas DavisDepartment of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-1576-7998
Francesca AzzatoVictorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
George TaiaroaDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Jeff SzerDepartment of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-6783-2301
David RoutledgeDepartment of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Olivia SmibertDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. liv.smibert@austin.org.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain DiseasesHematopoietic Stem Cell TransplantationNeurotoxicity SyndromesHumansStem Cell Transplantation

Identifiers

PMID35411105
PMCPMC8995889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.